Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
CAS RN: 121268-17-5 | Product Number: A2456
Alendronate Sodium Trihydrate
Purity: >97.0%(T)
- Alendronic Acid Monosodium Salt Trihydrate
- (4-Amino-1-hydroxy-1-phosphonobutyl)phosphonic Acid Monosodium Salt Trihydrate
- Monosodium (4-Amino-1-hydroxy-1-phosphonobutyl)phosphonate Trihydrate
Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
---|---|---|---|---|---|
5G |
$89.00
|
1 | Contact Us | ≥100 |
|
25G |
$267.00
|
2 | 1 | ≥60 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | A2456 |
Purity / Analysis Method | >97.0%(T) |
Molecular Formula / Molecular Weight | C__4H__1__2NNaO__7P__2·3H__2O = 325.13 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Frozen (<0°C) |
Condition to Avoid | Heat Sensitive |
CAS RN | 121268-17-5 |
Related CAS RN | 66376-36-1&129318-43-0 |
Reaxys Registry Number | 6947932 |
PubChem Substance ID | 135727181 |
Merck Index (14) | 229 |
MDL Number | MFCD01748233 |
Appearance | White to Almost white powder to crystal |
Purity(Neutralization titration) | min. 97.0 % |
Drying loss | 16.1 to 17.1 % |
Solubility in water | Slightly soluble |
Solubility (insoluble in) | Chloroform |
RTECS# | SZ6523666 |
HS Number | 2931.90.9052 |
References
- Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure
- Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
- Synthesis, characterization and biodistribution of bisphosphonates Sm-153 complexes: correlation with molecular modeling interaction studies
- Synthesis and Study of Alendronate Derivatives as Potential Prodrugs of Alendronate Sodium for the Treatment of Low Bone Density and Osteoporosis
References
- 1)Anti-bone resorption
- a)J. E. Dunford, K. Thompson, F. P. Coxon, S. P. Luckman, F. M. Hahn, C. D. Poulter, F. H. Ebetino, M. J. Rogers., J. Pharmacol. Exp. Ther. 2001, 296, 235.
- b)E. Hiroi-Furuya, T. Kameda, K. Hiura, H. Mano, K. Miyazawa, Y. Nakamaru, M. Watanabe-Mano, N. Okuda, J. Shimada, Y. Yamamoto, Y. Hakeda, M. Kumegawa, Calcif. Tissue Int. 1999, 64, 219.
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.